Profund Advisors LLC Nurix Therapeutics, Inc. Transaction History
Profund Advisors LLC
- $2.7 Billion
- Q2 2025
A detailed history of Profund Advisors LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Profund Advisors LLC holds 16,433 shares of NRIX stock, worth $210,013. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,433
Previous 23,187
29.13%
Holding current value
$210,013
Previous $275,000
32.0%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding NRIX
# of Institutions
175Shares Held
79.5MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$87.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$77.5 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$57.1 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$50.5 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$49.6 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $603M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...